Risk Factors for Perimegaprosthetic Infections After Tumor Resection
Marco De Gori, MD; GiorGio Gasparini, MD; roDolfo capanna, MD P eriprosthetic joint infection remains one of the most challenging complications following joint replacement and a leading cause of early implant failure. 1 Although the overall infection rate is relatively low, being approximately 1% following hip and knee arthroplasties, 2 it might dramatically increase in the presence of factors such as patients' immunosuppression, extensive soft tissue dissection, long operating times, 3 and neoplastic diseases. 4 A deep infection may be a devastating complication following megaprosthetic replacement after tumor resection, leading to challenges in treatment decisions 5 and posing a high risk for repeated surgical procedures, prolonged hospital stay and rehabilitation, pain, poor functional outcome, and failed limb salvage. 3, 6, 7 Overall, a recent systematic review 8 reported a mean rate of perimegaprosthetic infection (PMI) of 10%; notably, a PMI rate as high as 43% may follow revision surgery. 9 It has been suggested that longterm antibiotic prophylaxis decreases the risk of PMIs, 8 but controversy remains about the role of other factors in the development of PMIs, thus supporting the need for a comprehensive literature review.
The purpose of this study was to systematically evaluate published clinical studies determining which variables predict the PMI rate after tumor resection.
Materials and Methods
The authors conducted a systematic literature search using the MEDLINE/ PubMed and Cochrane Register of Controlled Trials databases. They wanted to identify and include in the search all English-language studies addressing septic complications of the use of megaprostheses in the treatment of bone tumors including an analysis of risk factors for PMIs. Level V studies were excluded from the search.
The MEDLINE/PubMed search was performed as follows: 1: "megaprosth* infect*" AND "English" [ The search of the Cochrane Register of Controlled Trials database was performed using the terms "megaprosth*" OR "tumor* endoprosth*" AND "infect*".
This search identified 249 pertinent records. These records were reviewed and cross-referenced to exclude repeated references, leaving 236 articles for review. Overall, 212 articles were excluded on the basis of titles or abstracts. Full-text articles were then retrieved and reviewed, in full, for the remaining 24 studies. Reference sections of all articles were searched for undetected studies, thus adding 9 studies to the review. Of the 33 studies, 25 were further excluded on the basis of the fulltext review. The remaining 8 articles [10] [11] [12] [13] [14] [15] [16] [17] met the inclusion criteria and were analyzed in this systematic review (Figure) .
results

Study Characteristics
All included studies ( Table 1) retrospectively reviewed a series of patients having undergone a megaprosthetic replacement after tumor resection (level IV studies). These studies reported on a total of 2136 patients (range, 62-1161 per study); the mean patient age was 33.3 years (range, 5-90 years). In 2 studies, 10, 13 megaprostheses were used to treat lesions located in either the femur, tibia, humerus, or pelvis; 2 studies 14, 17 included only lesions of the proximal tibia; 2 studies 11, 12 included only lesions of the femur and tibia; 1 study 15 included only lesions of the proximal femur; and 1 study 16 included lesions located in either the distal femur or the proximal tibia. The mean PMI rate was 14.2% (range, 7.2%-25.8%), with PMIs having occurred from 9 days to 240 months postoperatively.
Statistical analysis of risk factors for PMIs was performed through KaplanMeier survival curve comparisons (ie, using the Mantel-Cox log-rank test) in 5 studies, 11, 12, [14] [15] [16] logistic regression analysis (ie, using the Hosmer-Lemeshow goodness-of-fit test) in 1 study, 13 comparative statistics (ie, using the chi-square test) in 1 study, 17 and preliminary comparative statistics (ie, using the chi-square test, Fisher's exact test, the Student's t test, or the Mann-Whitney U test, when appropriate) followed by stepwise logistic regression analysis in 1 study.
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Patient-Related Factors
All of the evaluated risk factors are summarized in Table 2 . Patients' sex and age at surgery were not found to influence PMI rate. 10, 13, 14, 16 Increasing body mass index was associated with a significantly higher risk of PMI. 13 Overall, the presence of comorbidities was also associated with PMIs, 10 but neither a higher American Society of Anesthesiologists score 10 nor the presence of diabetes mellitus 13 specifically increased the risk. Perimegaprosthetic infections were also found to be more frequent with a coexisting skin necrosis or a superficial surgical site infection. 16 Preoperative white blood cell count, 14 febrile neutropenia, 13, 14 bacteremia, 13 and the use of an indwelling port system 14 were not associated with the development of a PMI.
Disease-Related Factors
Six studies 10, 11, [13] [14] [15] [16] explored the role of lesion histology and tumor characteristics in determining PMI rate. Controversy remains regarding whether primary or metastatic lesions have a higher risk of PMI. 11, 15 Among primary tumors, no significant differences in PMI rates were found according to histological features 10, 11, 14 and metastatic spread at diagnosis. 10, 13 No significant effects of chemotherapy 10, 11, 13, 14, 16 and radiotherapy 10, 11, 15 were found for the development of a PMI.
Five studies [10] [11] [12] 15, 16 explored the role of localization of lesions in determining PMI rate. Proximal tibial and pelvic locations were identified as strong risk factors for PMIs 10 ; in particular, pelvic extension of proximal femoral disease has led to a higher PMI rate than that following reconstruction of the proximal femur alone. 15 Conversely, distal femoral location of the lesion appears to be a protective factor for PMI.
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Procedure-Related Factors
A preoperative hospitalization of more than 48 hours has been found to predict a higher risk of PMI. 10 Overall, features of perioperative antibiotic prophylaxis do not act as risk factors for PMIs; indeed, no significant differences in PMI rates have been found according to the choice of antibiotic used, 13 the intraoperative dosing, 13 the number of postoperative antibiotics used, 16 and the length of postoperative prophylaxis. 13, 14 Specific operative features have been widely explored. No significant effects of the use of a clean air operating room were found for the development of a PMI. 16 Two studies 11, 15 have shown that the use of a cemented megaprosthesis has led to a higher PMI rate than that following the use of an uncemented megaprosthesis; conversely, there were no statistical differences in PMI rates according to prosthesis type 10, 16 or hinge movement. 11 Overall, width of resection margins, 10 bone resection length, 10, 14, 16 and extracapsular resection of knee tumors 16 do not affect PMI rate; however, resection of greater than 37% of the proximal tibia was found to be related to a higher PMI rate.
14 In distal femoral lesions, resection of 3 or 4 heads of the quadriceps muscle was associated with a significantly higher PMI rate than resection of 2 or fewer heads. 16 The need for additional surgical procedures after the megaprosthesis implantation was associated with a higher risk of PMI. 10 Two 10, 13 of 3 studies 10,13,14 agreed that increasing surgical times statistically correlated with PMI rate; in particular, an operation lasting longer than 2.5 hours is a strong risk factor for the development of a PMI. 10 One 17 of 3 studies 13, 16, 17 indicated that the routine use of a gastrocnemius flap for anterior reconstruction and megaprosthesis coverage following a proximal tibial resection led to a significant reduction of PMI rate. On the other hand, the PMI rate 
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14 An increased risk of PMIs was found for patients who needed a postoperative admission to the intensive care unit and for those having experienced a postoperative hematoma. 13 Despite the fact that the estimated blood loss was not higher in patients with a PMI, 10 two 10,13 of 3 studies 10, 13, 14 detected that an increased postoperative blood transfusion requirement posed a higher risk of PMI; in particular, transfusion of 2 or more units of allogeneic packed cells emerged as a predictor of PMI.
discussion
Due to improved imaging modalities, understanding of tumor biology, and ad- 
vances in adjuvant treatments, limb amputation is now used selectively in the treatment of bone tumors. 18 Indeed, limb salvage surgery has become the standard of care for bone tumors, being applicable for up to 85% of patients 18 and resulting in limb salvage for up to 90% of them. 19 Because the use of megaprostheses is currently gaining momentum as the most common reconstructive technique after tumor resection, 12, 20 the goal of this systematic review was to identify factors affecting the risk of PMIs. Notably, the presence of several conflicting results together with the lack of comprehensive reviews to date exploring the exact causative factors for PMIs has often led to extending to megaprostheses previous information on risk factors for periprosthetic joint infections resulting from the analysis of primary arthroplasties. 5 Both the presence of comorbidities and a higher body mass index at surgery have been reported as significant patient-related risk factors for PMIs. Of interest, the direct association between body mass index and infection rate is well established in conventional arthroplasties, as obesity increases both the morbidity from osteoarthritis and the risk of periprosthetic joint infections 21 ; conversely, caution should be exercised in applying this risk factor to the tumor megaprosthesis population, as up to 18% of previous cohorts 13 were underweight.
Localization of lesions was found to be an important risk factor for PMIs, with higher rates expected following megaprosthetic replacement of both pelvic and proximal tibial tumors. As previously argued, 10 long operating times because of the complex anatomy, large bone defects after tumor resection, and difficulty in achieving wide surgical margins are all factors accounting for challenges in pelvic surgery. On the other hand, the high PMI rate following proximal tibial tumor resection may correlate with the difficulty in achieving a good soft tissue coverage, thus being confirmed by the marked reduction in PMI rate following the routine use of gastrocnemius flaps as part of the reconstruction. 17 Notably, soft tissue condition has been shown to be a strong predictor of PMI and the most important risk factor for failed limb salvage. 7 The most important finding of this systematic review was that the majority of factors accounting for a higher PMI rate are related to both surgical procedure and hospitalization. Of interest, prolonged preoperative hospital stay and operative time, [22] [23] [24] the presence of postoperative hematoma, 25 and the increasing number of allogeneic blood transfusions 26 are all proven risk factors for periprosthetic joint infections, and their role has been confirmed following megaprosthetic replacement after tumor resection. The results of the current review indicate that the features of perioperative antibiotic prophylaxis do not act as risk factors for PMIs, thus contradicting a previously published systematic review. 8 However, evidence and guidelines directing the prescription of prophylactic antibiotic regimens in musculoskeletal tumor surgery are lacking, so considerable variation in strategies exists. 27 Of interest, this review found agreement that a higher PMI rate can be expected in cemented than in cementless megaprostheses, [11] [12] [13] [14] [15] thus contradicting information regarding conventional arthroplasties. 28 However, factors such as the antibiotic loading of acrylic cement, 29 megaprosthesis alloy system, 30 and surface treatments 31 are all pertinent to consider.
This systematic review had limitations. First, the lack of randomized controlled trials (level I or II) on the role of specific factors in the development of PMIs impeded the performance of a strict metaanalysis to draw firm and univocal conclusions. In addition, there is wide variability in the reporting of risk factors for PMIs. Notably, none of the studies considered included all of the factors studied. Moreover, there is variability in the statistical measures used. These issues combined make it difficult to compare the results for all of the factors important to the surgeon and the patient.
conclusion
This systematic review identified the role of several factors in the development of PMIs after tumor resection. Identified factors mostly relate to both surgical procedure and hospitalization. Therefore, there are several modifiable risk factors for PMIs. Physicians should consider these results when discussing the outcomes of limb salvage surgery with patients and trying to reduce the overall burden of PMIs.
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